Related references
Note: Only part of the references are listed.Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway
Annamaria Spina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells
Zan Chen et al.
ACTA PHARMACOLOGICA SINICA (2012)
Cell surface receptor expression patterns in osteosarcoma
Sheref E. Hassan et al.
CANCER (2012)
Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo
Jiro Ichikawa et al.
CANCER (2012)
Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma
Takanao Sueyoshi et al.
CANCER LETTERS (2012)
HMGB1 Promotes Drug Resistance in Osteosarcoma
Jun Huang et al.
CANCER RESEARCH (2012)
Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Kristiaan Lenos et al.
CANCER RESEARCH (2012)
miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
Kevin B. Jones et al.
CANCER RESEARCH (2012)
Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling
Yonggang Li et al.
FEBS JOURNAL (2012)
P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma
Daria Brambilla et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Exploration of a new drug that targets YAP
Makiko Fujii
JOURNAL OF BIOCHEMISTRY (2012)
HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis
Dan Liang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
David Ebb et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma
Wang Yu-Cai et al.
ACTA HISTOCHEMICA (2011)
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3
Li-hong Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Genetic Amplification of the Vascular Endothelial Growth Factor (VEGF) Pathway Genes, Including VEGFA, in Human Osteosarcoma
Jilong Yang et al.
CANCER (2011)
A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription
Yijun Bao et al.
JOURNAL OF BIOCHEMISTRY (2011)
CYR61 Downregulation Reduces Osteosarcoma Cell Invasion, Migration, and Metastasis
Olivia Fromigue et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression
Mitsuhiko Osaki et al.
MOLECULAR THERAPY (2011)
Functional and biological analysis of Bcl-xL expression in human osteosarcoma
Zhao-Xia Wang et al.
BONE (2010)
Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma
Jilong Yang et al.
CANCER LETTERS (2010)
High Wnt Signaling Represses the Proapoptotic Proteoglycan syndecan-2 in Osteosarcoma Cells
Francois-Xavier Dieudonne et al.
CANCER RESEARCH (2010)
The kinase Mirk is a potential therapeutic target in osteosarcoma
Cao Yang et al.
CARCINOGENESIS (2010)
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma
Yongping Cai et al.
JOURNAL OF PATHOLOGY (2010)
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Bo Song et al.
MOLECULAR CANCER (2010)
c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
T. Shimizu et al.
ONCOGENE (2010)
Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness
P. Zhang et al.
ONCOGENE (2010)
IKKγ protein is a target of BAG3 regulatory activity in human tumor growth
Massimo Ammirante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival
Jilong Yang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2010)
Modulation of the E2F1-Driven Cancer Cell Fate by the DNA Damage Response Machinery and Potential Novel E2F1 Targets in Osteosarcomas
Michalis Liontos et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
Kazuhito Morioka et al.
CANCER SCIENCE (2009)
Functional genome screen for therapeutic targets of osteosarcoma
Umio Yamaguchi et al.
CANCER SCIENCE (2009)
Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics
Annette S. Gillings et al.
FEBS JOURNAL (2009)
The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines
Jennifer K. McCleese et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2
Sebastien Salas et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells
Yin-He Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
M. Enomoto et al.
ONCOGENE (2009)
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
X. Wan et al.
ONCOGENE (2009)
Recurrent RECQL4 Imbalance and Increased Gene Expression Levels Are Associated with Structural Chromosomal Instability in Sporadic Osteosarcoma
Georges Maire et al.
NEOPLASIA (2009)
Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Recombinant antisense c-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin
XK Xie et al.
CANCER INVESTIGATION (2006)
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma
XL Wan et al.
CANCER RESEARCH (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
